J Frontier Co.,Ltd. (2934) Cash flow
Market cap
¥9.1B
P/E ratio
16.9x
J-Frontier develops and sells health supplements and pharmaceuticals while operating SOKUYAKU, a medical platform for online consultations and prescription delivery.
| 2019/05 | 2020/05 | 2021/05 | 2022/05 | 2023/05 | 2024/05 | 2025/05 | 2026/05 | |
| Depreciation & amortization | 7 | 12 | 5 | 10 | 24 | 47 | 31 | 37 |
| Cash from operations | 14 | 218 | 831 | -367 | -1,830 | -1,436 | 509 | 454 |
| Capital expenditures | -34 | -5 | -7 | -8 | -100 | -91 | -39 | -59 |
| Cash from investing | -63 | -165 | -8 | -860 | -1,133 | -1,793 | 471 | -1,190 |
| Repurchases of common stock | - | - | - | -453 | -0 | -0 | -0 | -0 |
| Proceeds from issuance of term debt, net | 200 | - | - | 200 | 1,500 | 2,877 | 145 | 1,417 |
| Repayments of term debt | -70 | -100 | -94 | -77 | -320 | -950 | -1,199 | -1,251 |
| Cash from financing | 130 | -99 | -94 | 2,565 | 1,451 | 3,391 | -623 | 758 |